Cargando…
Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
BACKGROUND: Acute respiratory distress syndrome (ARDS) in humans is caused by an unchecked proinflammatory response that results in diffuse and severe lung injury, and it is associated with a mortality rate of 35 to 45%. Mesenchymal stromal cells (MSCs; ‘adult stem cells’) could represent a promisin...
Autores principales: | Lalu, Manoj M, Moher, David, Marshall, John, Fergusson, Dean, Mei, Shirley HJ, Macleod, Malcolm, Griffin, Gilly, Turgeon, Alexis F, Rudnicki, Michael, Fishman, Jason, Avey, Marc T, Skidmore, Becky, Grimshaw, Jeremy M, Stewart, Duncan J, Singh, Kavita, McIntyre, Lauralyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046388/ https://www.ncbi.nlm.nih.gov/pubmed/24887266 http://dx.doi.org/10.1186/2046-4053-3-48 |
Ejemplares similares
-
Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review
por: McIntyre, Lauralyn A., et al.
Publicado: (2016) -
The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research
por: Avey, Marc T., et al.
Publicado: (2016) -
Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
por: Barron, Carly C., et al.
Publicado: (2017) -
Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
por: Lalu, Manoj M, et al.
Publicado: (2016) -
Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol
por: Suen, Colin M., et al.
Publicado: (2016)